Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2020Biomaterials ScienceOpen Access

Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases

View Full Paper
Ask AI
Bookmark
Share

Authors

SAShima Masoudi AsilThe University of Texas at El PasoJAJyoti AhlawatMaharshi Dayanand UniversityGBGileydis Guillama BarrosoCentro Nacional de Investigaciones Científicas

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Asil et al. (2020) studied this question.

synapsesocial.com/papers/6a0246762eefac861c75fdf5https://doi.org/10.1039/d0bm00809e
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Method to Impart Electro- and Biofunctionality to Neural Scaffolds Using Graphene–Polyelectrolyte Multilayers2012 · 87 citations
  2. 2Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer’s disease2018 · 218 citations
  3. 3Carbon nanotubes and graphene as emerging candidates in neuroregeneration and neurodrug delivery2015 · 104 citations
  4. 4RNA metabolism in neurodegenerative disease2017 · 144 citations
  5. 5Small-Sized mPEG–PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity2017 · 88 citations